Gene: CEBPD

1052
C/EBP-delta|CELF|CRP3|NF-IL6-beta
CCAAT enhancer binding protein delta
protein-coding
8q11.21
Ensembl:ENSG00000221869 MIM:116898 Vega:OTTHUMG00000162290 UniprotKB:P49716
NC_000008.11
PubMed
0   ANCO-SNPs
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
5.491e-1 (AD)  1.352e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
YBX30.889
TNFRSF1A0.868
GADD45B0.863
SOCS30.863
CDKN1A0.856
RAB200.848
PNP0.842
IFITM30.84
IFITM20.834
PXDC10.833

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PPEF1-0.562
ABCC12-0.561
NEUROD6-0.557
NXPH2-0.547
XKR4-0.544
CASC15-0.537
LHX6-0.528
GRIN3A-0.525
VWC2-0.524
MARCH4-0.521

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C02017516 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione"[16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione co-treated with PGR protein] results in increased expression of CEBPD mRNA"21130152
C0512461-methylanthracene[1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPD mRNA28329830
C0326681-nitropyrene1-nitropyrene results in decreased expression of CEBPD mRNA19041380
C5544281-nitrosocyclohexyl acetate1-nitrosocyclohexyl acetate inhibits the reaction [LIF protein results in increased activity of CEBPD protein]22905257
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEBPD mRNA"25614096
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of CEBPD mRNA"19095052
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CEBPD mRNA"19114083
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA"19167446
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of CEBPD mRNA"21346803
C5185762-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate"2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate results in increased expression of CEBPD mRNA"17327690
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in decreased expression of CEBPD mRNA"18648102
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
D000082AcetaminophenAcetaminophen affects the expression of CEBPD mRNA25064622
D000082AcetaminophenAcetaminophen results in decreased expression of CEBPD mRNA21420995
D000082AcetaminophenAcetaminophen affects the expression of CEBPD mRNA17562736
D000082Acetaminophen[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPD mRNA17585979
D000082AcetaminophenPPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPD mRNA]17585979
D020106AcrylamideAcrylamide results in increased expression of CEBPD mRNA28959563
C006418adrenocorticotropin zincadrenocorticotropin zinc results in increased expression of CEBPD mRNA19920212
D000638AmiodaroneAmiodarone affects the expression of CEBPD mRNA25064622
D003913DextroamphetamineDextroamphetamine results in increased expression of CEBPD mRNA12558987
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of CEBPD mRNA24449571
C006632arsenic trioxidearsenic trioxide results in increased expression of CEBPD mRNA26705709
C006632arsenic trioxide[Tretinoin co-treated with arsenic trioxide] results in decreased expression of CEBPD mRNA15894607
D001507BeclomethasoneBeclomethasone results in increased expression of CEBPD mRNA23656298
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of CEBPD mRNA22316170
D001564Benzo(a)pyreneBenzo(a)pyrene affects the expression of CEBPD mRNA27195522
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of CEBPD mRNA21569818
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPD protein11779194
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydeQuercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPD protein]11779194
D004958EstradiolEstradiol affects the expression of CEBPD mRNA14699072
D004958Estradiol[Estradiol co-treated with Progesterone] results in increased expression of CEBPD mRNA20660070
D004958EstradiolEstradiol results in decreased expression of CEBPD mRNA16474171
D004958EstradiolEstradiol results in increased expression of CEBPD mRNA19153601
D004958EstradiolEstradiol results in decreased expression of CEBPD mRNA21980073
C006780bisphenol Abisphenol A results in decreased expression of CEBPD mRNA26364221
C006780bisphenol Abisphenol A affects the expression of CEBPD mRNA20170705
C006780bisphenol Abisphenol A results in decreased expression of CEBPD mRNA16474171
C006780bisphenol Abisphenol A promotes the reaction [[NR3C1 protein co-treated with CEBPD protein] results in increased expression of FABP4 mRNA]25068083
C006780bisphenol Abisphenol A results in increased expression of CEBPD mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of CEBPD gene28505145
C032036bromobenzenebromobenzene results in decreased expression of CEBPD mRNA12628495
D019256Cadmium ChlorideCadmium Chloride results in increased expression of CEBPD mRNA25993096
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of CEBPD mRNA27339419
C010063carbonyl sulfidecarbonyl sulfide results in increased expression of CEBPD mRNA19395590
C100187chloropicrinchloropicrin results in decreased expression of CEBPD mRNA26352163
D002737ChloropreneChloroprene results in increased expression of CEBPD mRNA23125180
D002746ChlorpromazineChlorpromazine affects the expression of CEBPD mRNA25064622
C074702chromium hexavalent ionchromium hexavalent ion affects the expression of CEBPD mRNA28472532
C031180chrysenechrysene results in decreased expression of CEBPD mRNA26377693
C418118CI 1044CI 1044 results in increased expression of CEBPD mRNA17569694
C039671ciglitazone[ciglitazone binds to PPARG protein] which results in increased expression of CEBPD mRNA16197558
D002922CiguatoxinsCiguatoxins affects the expression of CEBPD mRNA18353800
D002939CiprofloxacinCiprofloxacin inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased activity of CEBPD mRNA]11052920
D002994Clofibrate[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPD mRNA17585979
D002994ClofibrateClofibrate results in decreased expression of CEBPD mRNA17585979
D002994ClofibratePPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPD mRNA]17585979
D003345CorticosteroneCorticosterone results in increased expression of CEBPD mRNA15755911
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA"19167446
C041246cucurbitacin Bcucurbitacin B results in decreased expression of CEBPD24316209
C015763cumene[cumene co-treated with KRAS gene mutant form] results in decreased expression of CEBPD mRNA18648096
D003471CuprizoneCuprizone results in increased expression of CEBPD mRNA27523638
C057862cyanoginosin LRcyanoginosin LR results in decreased expression of CEBPD mRNA17383702
D016572CyclosporineCyclosporine affects the expression of CEBPD mRNA25064622
D016572CyclosporineCyclosporine results in decreased expression of CEBPD mRNA22147139|2556210
D003561CytarabineCytarabine results in decreased expression of CEBPD mRNA21198554
C014347decitabinedecitabine affects the methylation of CEBPD promoter17234736
C014347decitabine[decitabine affects the methylation of CEBPD promoter] which affects the expression of CEBPD mRNA17234736|1723473
D003907Dexamethasone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA16054899
D003907DexamethasoneDexamethasone results in increased expression of CEBPD mRNA20032058
D003907DexamethasoneTestosterone inhibits the reaction [Dexamethasone results in increased expression of CEBPD mRNA]20032058
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of CEBPD mRNA17361019|2126653
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of CEBPD mRNA21266533|2174549
D002945CisplatinCisplatin results in decreased expression of CEBPD mRNA27392435
D002945CisplatinCisplatin results in increased expression of CEBPD mRNA19561079
D002945CisplatinCisplatin affects the expression of CEBPD mRNA21151649
D002945CisplatinCisplatin inhibits the reaction [trichostatin A results in decreased expression of CEBPD mRNA]23558232
D004026DieldrinDieldrin results in decreased expression of CEBPD mRNA20584760
D004041Dietary FatsDietary Fats results in decreased expression of CEBPD mRNA18042831|1903023
D004041Dietary Fatsrimonabant inhibits the reaction [Dietary Fats results in decreased expression of CEBPD mRNA]19030233
D004041Dietary Fats[Dietary Fats co-treated with resveratrol] results in increased expression of CEBPD mRNA21852083
D019422Dietary SucroseDietary Sucrose results in increased expression of CEBPD mRNA26033743
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of CEBPD mRNA19371625
D002117CalcitriolCalcitriol results in increased expression of CEBPD mRNA21592394
D002117Calcitriol[Testosterone co-treated with Calcitriol] results in increased expression of CEBPD mRNA21592394
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of CEBPD mRNA25380136
D004147DioxinsDioxins affects the expression of CEBPD mRNA20463971
C012301domoic aciddomoic acid results in increased expression of CEBPD mRNA18936300
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CEBPD mRNA22079256
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of CEBPD mRNA25064622
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of CEBPD mRNA20227414
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of CEBPD mRNA20170705
D015025ZearalenoneZearalenone results in increased expression of CEBPD mRNA19371625
D005419FlavonoidsFlavonoids results in increased expression of CEBPD mRNA18035473
C007738fluoranthene[1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPD mRNA28329830
D005557FormaldehydeFormaldehyde results in decreased expression of CEBPD mRNA20655997
C069837fullerene C60fullerene C60 results in decreased expression of CEBPD mRNA19167457
C070081fulvestrantfulvestrant results in increased expression of CEBPD mRNA21980073
C039281furanfuran results in increased expression of CEBPD mRNA27387713
C007834genipingenipin inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPD mRNA]22687549
D019833GenisteinGenistein results in decreased expression of CEBPD mRNA16474171
D019833GenisteinGenistein results in increased expression of CEBPD mRNA19371625
D005897GlafenineGlafenine results in increased expression of CEBPD mRNA24136188
D005947GlucoseCEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]24376792
D005947GlucoseCEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]24376792
D005947GlucoseGlucose promotes the reaction [CEBPD protein binds to EDN1 promoter]24376792
D005947GlucoseGlucose results in increased localization of and results in increased activity of CEBPD protein24376792
D005947Glucosepyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]24376792
D005947GlucoseSB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]24376792
D005947GlucoseU 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]24376792
D017313FenretinideFenretinide results in increased expression of CEBPD mRNA28973697
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of CEBPD mRNA26846883
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of CEBPD mRNA20044591
C475919hydroxytamoxifenGPER1 protein affects the reaction [hydroxytamoxifen results in increased expression of CEBPD mRNA]19153601
C475919hydroxytamoxifenhydroxytamoxifen results in increased expression of CEBPD mRNA19153601
C492448ICG 001ICG 001 results in increased expression of CEBPD mRNA26191083
C041508indeno(1,2,3-cd)pyrene"indeno(1,2,3-cd)pyrene results in decreased expression of CEBPD mRNA"26377693
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CEBPD mRNA25613284
C051890irinotecanirinotecan results in increased expression of CEBPD mRNA20097248
D0150561-Methyl-3-isobutylxanthine[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA16054899
D007529IsoflavonesIsoflavones results in decreased expression of CEBPD mRNA17374662
D007538IsoniazidIsoniazid results in decreased expression of CEBPD mRNA24128855
D007538IsoniazidIsoniazid results in decreased expression of CEBPD protein24128855
D007545IsoproterenolIsoproterenol results in increased expression of CEBPD mRNA20003209
C098607JP8 aviation fuelJP8 aviation fuel results in increased expression of CEBPD protein17337753
C011890kojic acidkojic acid results in increased expression of CEBPD mRNA16595896
C067713lactacystinlactacystin results in increased expression of CEBPD protein11779194
D007854LeadLead affects the expression of CEBPD mRNA28903495
C018584linaloollinalool results in increased expression of CEBPD mRNA20536181
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in increased expression of CEBPD mRNA"24972896
C440499lipopolysaccharide, Escherichia coli O111 B4"lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CEBPD mRNA"25164664
D008070Lipopolysaccharidesgenipin inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPD mRNA]22687549
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of CEBPD mRNA22687549|2589032
D008070LipopolysaccharidesAPP protein modified form inhibits the reaction [Lipopolysaccharides results in increased activity of CEBPD protein]18405661
D008070LipopolysaccharidesAPP protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPD protein]18405661
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of and results in increased activity of CEBPD protein18405661
D008070Lipopolysaccharides[[Lipopolysaccharides co-treated with IFNG protein] co-treated with APP protein modified form] results in increased activity of CEBPD protein15223066
D018021Lithium ChlorideLithium Chloride results in increased expression of CEBPD mRNA23527032
D058185Magnetite Nanoparticles[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CEBPD mRNA21641980
D008344Maneb[Paraquat co-treated with Maneb] affects the expression of CEBPD mRNA22563483
D008345ManganeseManganese results in increased expression of CEBPD mRNA17175027
C025340manganese chloridemanganese chloride results in increased expression of CEBPD mRNA17175027
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
D008627Mercuric ChlorideMercuric Chloride results in increased expression of CEBPD mRNA20353558
D008627Mercuric ChlorideMercuric Chloride results in increased expression of CEBPD mRNA16507785
D008628MercuryMercury results in decreased expression of CEBPD mRNA19937285
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of CEBPD mRNA28001369
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of CEBPD mRNA26011545
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CEBPD mRNA"20188158
C406082monomethylarsonous acidmonomethylarsonous acid results in increased expression of CEBPD mRNA20024957
D009151Mustard GasMustard Gas results in increased expression of CEBPD mRNA18955075
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of CEBPD mRNA"24389112
D037742Nanotubes, Carbon"Nanotubes, Carbon analog affects the expression of CEBPD mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of CEBPD mRNA"25620056
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of CEBPD mRNA"25554681|2562005
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of CEBPD mRNA25380136
C017096n-butoxyethanoln-butoxyethanol results in increased expression of CEBPD mRNA19812364
C010463n-hexanaln-hexanal affects the expression of CEBPD mRNA26880647
D009525NiacinNiacin results in increased expression of CEBPD mRNA19131065
D009532NickelNickel results in increased expression of CEBPD mRNA24768652
C119536nickel acetatenickel acetate affects the expression of CEBPD mRNA12915101
C022838nickel chloridenickel chloride results in increased expression of CEBPD mRNA17312168
C028007nickel monoxidenickel monoxide results in decreased expression of CEBPD mRNA19167457
C014707nitrosobenzylmethylaminenitrosobenzylmethylamine results in increased expression of CEBPD mRNA17616710
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of CEBPD mRNA"12756304
C510784ormosil[ormosil binds to Polyethylene Glycols] which results in decreased expression of CEBPD mRNA24888373
D010100OxygenOxygen deficiency results in increased expression of CEBPD mRNA17175027|2651600
D010100OxygenOxygen results in increased expression of CEBPD mRNA19747560
D010126Ozone"[Water Pollutants, Chemical co-treated with Ozone] results in increased expression of CEBPD mRNA"23246600
D010126OzoneOzone results in decreased expression of CEBPD mRNA16716893
D017239PaclitaxelPaclitaxel results in increased expression of CEBPD mRNA18754875
D000073878Palm OilPalm Oil results in decreased expression of CEBPD mRNA18042831
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of CEBPD mRNA26272509
C016030pantogabpantogab results in increased expression of CEBPD mRNA17379144
D010269ParaquatParaquat affects the expression of CEBPD mRNA25064622
D010269Paraquat[Paraquat co-treated with Maneb] affects the expression of CEBPD mRNA22563483
D010269ParaquatParaquat results in decreased expression of CEBPD mRNA22563483
C086401pentabromodiphenyl etherpentabromodiphenyl ether analog results in increased expression of CEBPD mRNA19095052
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in increased expression of CEBPD mRNA26705709
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of CEBPD mRNA16221955
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in increased expression of CEBPD mRNA19747560
D010634PhenobarbitalPhenobarbital affects the expression of CEBPD mRNA23091169
D010634PhenobarbitalPhenobarbital results in decreased expression of CEBPD mRNA19270015
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of CEBPD mRNA26272509
D010705PhosgenePhosgene affects the expression of CEBPD mRNA16300373
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEBPD mRNA19710929
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CEBPD mRNA19710929
C006253pirinixic acidpirinixic acid results in increased expression of CEBPD mRNA18445702
D011078Polychlorinated BiphenylsPolychlorinated Biphenyls analog results in decreased expression of CEBPD mRNA16474171
D011092Polyethylene Glycols[ormosil binds to Polyethylene Glycols] which results in decreased expression of CEBPD mRNA24888373
C467566pomalidomidepomalidomide results in increased expression of CEBPD mRNA15292067
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CEBPD mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of CEBPD mRNA22079256
D017035PravastatinPravastatin results in increased expression of CEBPD mRNA27225895
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of CEBPD mRNA28903501
D011374Progesterone[Estradiol co-treated with Progesterone] results in increased expression of CEBPD mRNA20660070
D011374ProgesteroneProgesterone results in increased expression of CEBPD mRNA18037150|2179573
D011374ProgesteroneProgesterone affects the expression of CEBPD mRNA17251523
D011374ProgesteroneProgesterone results in increased expression of CEBPD mRNA20726854
C010313pseudocumenepseudocumene results in increased expression of CEBPD protein17337753
C513428pyrachlostrobinpyrachlostrobin results in increased expression of CEBPD mRNA27029645
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]24376792
C428725pyridabenpyridaben results in decreased expression of CEBPD mRNA22563483
D011794QuercetinQuercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPD protein]11779194
C005266quinomethionatequinomethionate affects the expression of CEBPD mRNA15387888
D017382Reactive Oxygen SpeciesReactive Oxygen Species results in decreased expression of CEBPD mRNA25800948
C059514resveratrolresveratrol results in decreased expression of CEBPD mRNA15280659
C059514resveratrolresveratrol results in increased expression of CEBPD mRNA19371625
C059514resveratrol[resveratrol co-treated with Streptozocin] results in increased expression of CEBPD mRNA25905778
C059514resveratrolresveratrol results in increased expression of CEBPD mRNA25905778
C059514resveratrol[Dietary Fats co-treated with resveratrol] results in increased expression of CEBPD mRNA21852083
C089032rimonabantrimonabant inhibits the reaction [Dietary Fats results in decreased expression of CEBPD mRNA]19030233
C089730rosiglitazone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA16054899
C093642SB 203580SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]24376792
D012822Silicon DioxideSilicon Dioxide results in increased expression of CEBPD mRNA23221170
D012834SilverSilver results in increased expression of CEBPD mRNA28959546
C009277sodium arsenatesodium arsenate results in decreased expression of CEBPD mRNA21795629
C009277sodium arsenatesodium arsenate results in increased expression of CEBPD mRNA21795629
C016104sodium bichromatesodium bichromate results in increased expression of CEBPD mRNA25993096
D053260SootSoot results in increased expression of CEBPD mRNA22461453|2655175
C471405sorafenibsorafenib promotes the reaction [CEBPD protein binds to GADD45G promoter]26172295
C471405sorafenibsorafenib results in increased expression of CEBPD protein26172295
C075117squalestatin 1squalestatin 1 affects the expression of CEBPD mRNA27225895
C075117squalestatin 1squalestatin 1 results in decreased expression of CEBPD mRNA27225895
D013311Streptozocin[resveratrol co-treated with Streptozocin] results in increased expression of CEBPD mRNA25905778
C041711St. Thomas' Hospital cardioplegic solutionSt. Thomas' Hospital cardioplegic solution results in increased expression of CEBPD mRNA16214533
D004113Succimer[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CEBPD mRNA21641980
C061133tamibarotenetamibarotene results in increased expression of CEBPD mRNA15498508
D013629TamoxifenTamoxifen affects the expression of CEBPD mRNA20937368
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid results in increased expression of CEBPD mRNA15885361
C501413tesaglitazartesaglitazar results in decreased expression of CEBPD mRNA21515302
D013739Testosterone[Testosterone co-treated with Calcitriol] results in increased expression of CEBPD mRNA21592394
D013739TestosteroneTestosterone results in decreased expression of CEBPD mRNA21592394
D013739TestosteroneTestosterone inhibits the reaction [Dexamethasone results in increased expression of CEBPD mRNA]20032058
C020806tetrabromobisphenol Atetrabromobisphenol A results in increased expression of CEBPD mRNA25172293
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of CEBPD mRNA17101203
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CEBPD mRNA20106945|2163298
D013749TetrachlorodibenzodioxinCEBPD protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA]16615095
D013749TetrachlorodibenzodioxinSRC protein promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CEBPD protein]14505802
D013749TetrachlorodibenzodioxinSRC protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPD mRNA]14505802
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CEBPD mRNA24058054
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CEBPD mRNA]15667827
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of CEBPD mRNA21889950
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased activity of CEBPD protein14505802
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CEBPD mRNA14505802|1740715
D013752TetracyclineTetracycline affects the expression of CEBPD mRNA25064622
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CEBPD mRNA25613284
D013853ThioacetamideThioacetamide affects the expression of CEBPD mRNA25064622
D013893ThiramThiram results in increased expression of CEBPD mRNA20530235
C009495titanium dioxidetitanium dioxide results in increased expression of CEBPD mRNA27760801
D019772TopotecanTopotecan results in increased expression of CEBPD mRNA25729387
D014212TretinoinTretinoin results in increased expression of CEBPD mRNA20530235
D014212Tretinoin[Tretinoin co-treated with arsenic trioxide] results in decreased expression of CEBPD mRNA15894607
D014212TretinoinTretinoin results in decreased expression of CEBPD mRNA15894607
D014212TretinoinTretinoin results in increased expression of CEBPD mRNA15498508|2383079
D014212TretinoinTretinoin results in decreased expression of CEBPD mRNA12969142
D014212TretinoinTretinoin results in decreased expression of CEBPD protein12969142
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of CEBPD mRNA24935251|2627250
C012589trichostatin ACisplatin inhibits the reaction [trichostatin A results in decreased expression of CEBPD mRNA]23558232
C012589trichostatin Atrichostatin A results in decreased expression of CEBPD mRNA23558232
C005445triphenyl phosphatetriphenyl phosphate results in increased expression of CEBPD mRNA28163246
C113580U 0126U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]24376792
C022884undecaneundecane results in increased expression of CEBPD protein17337753
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid results in increased expression of CEBPD mRNA15885361
D014635Valproic AcidValproic Acid affects the expression of CEBPD mRNA25064622
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
D014635Valproic AcidValproic Acid results in decreased expression of CEBPD mRNA25716160|2915479
D014635Valproic AcidValproic Acid results in increased expression of CEBPD mRNA23179753|2438349
D014635Valproic AcidValproic Acid results in increased methylation of CEBPD gene29154799
D014638VanadatesVanadates results in decreased expression of CEBPD mRNA22714537
D002762CholecalciferolCholecalciferol results in increased expression of CEBPD mRNA17170073
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA"27188386
C111237vorinostatvorinostat results in increased expression of CEBPD mRNA26272509
D014874Water Pollutants, Chemical"[Water Pollutants, Chemical co-treated with Ozone] results in increased expression of CEBPD mRNA"23246600
D015032ZincZinc results in increased expression of CEBPD mRNA17074742
D019287Zinc SulfateZinc Sulfate results in increased expression of CEBPD mRNA12756304
D019287Zinc SulfateZinc Sulfate results in increased expression of CEBPD mRNA17074742
C088658zoledronic acidzoledronic acid results in increased expression of CEBPD mRNA24714768

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000978RNA polymerase II proximal promoter sequence-specific DNA binding-IEA-  
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISA-  
GO:0001077transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding-IEA-  
GO:0005515protein binding-IPI20102225  20805509  
GO ID GO Term Qualifier Evidence PubMed
GO:0006366transcription by RNA polymerase II-TAS8314590  
GO:0019221cytokine-mediated signaling pathway-TAS-  
GO:0045944positive regulation of transcription by RNA polymerase II-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005654nucleoplasm-IDA-  
GO:0005654nucleoplasm-TAS-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1266738Developmental BiologyIEA
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-168256Immune SystemTAS
R-HSA-381340Transcriptional regulation of white adipocyte differentiationIEA
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-6785807Interleukin-4 and 13 signalingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
25514196Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer. (2015 Mar)Lv MExp Lung Res